Innate Pharma S.A. (EPA:IPH)
France flag France · Delayed Price · Currency is EUR
1.810
-0.002 (-0.11%)
Apr 1, 2025, 12:32 PM CET

Innate Pharma Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Operating Revenue
12.6351.949.5812.1156.16
Upgrade
Other Revenue
7.499.748.0912.5913.62
Upgrade
Revenue
20.1261.6457.6724.769.77
Upgrade
Revenue Growth (YoY)
-67.36%6.88%133.47%-64.59%-18.34%
Upgrade
Cost of Revenue
51.9856.0251.664749.71
Upgrade
Gross Profit
-31.865.626.01-22.320.07
Upgrade
Selling, General & Admin
19.7218.2922.4425.5218.99
Upgrade
Operating Expenses
19.7218.2922.4425.5218.99
Upgrade
Operating Income
-51.58-12.67-16.43-47.831.08
Upgrade
Interest Expense
-2.18-0.64-0.29-0.31-0.34
Upgrade
Interest & Investment Income
2.43.180.550.330.56
Upgrade
Currency Exchange Gain (Loss)
-1.80.910.831.25-1.58
Upgrade
Other Non Operating Income (Expenses)
3.681.65-1.631.08-0.55
Upgrade
EBT Excluding Unusual Items
-49.47-7.57-16.97-45.48-0.83
Upgrade
Asset Writedown
---41--
Upgrade
Pretax Income
-49.47-7.57-57.97-45.48-0.83
Upgrade
Earnings From Continuing Operations
-49.47-7.57-57.97-45.48-0.83
Upgrade
Earnings From Discontinued Operations
---0.13-7.33-63.16
Upgrade
Net Income
-49.47-7.57-58.1-52.81-63.98
Upgrade
Net Income to Common
-49.47-7.57-58.1-52.81-63.98
Upgrade
Shares Outstanding (Basic)
8180808079
Upgrade
Shares Outstanding (Diluted)
8180808079
Upgrade
Shares Change (YoY)
0.74%1.02%0.12%0.77%17.97%
Upgrade
EPS (Basic)
-0.61-0.09-0.73-0.66-0.81
Upgrade
EPS (Diluted)
-0.61-0.09-0.73-0.66-0.81
Upgrade
Free Cash Flow
-7.29-32.91-19.69-59.39-52.67
Upgrade
Free Cash Flow Per Share
-0.09-0.41-0.25-0.75-0.67
Upgrade
Gross Margin
-158.34%9.12%10.42%-90.28%28.76%
Upgrade
Operating Margin
-256.32%-20.55%-28.48%-193.60%1.55%
Upgrade
Profit Margin
-245.87%-12.28%-100.74%-213.78%-91.70%
Upgrade
Free Cash Flow Margin
-36.22%-53.39%-34.14%-240.40%-75.49%
Upgrade
EBITDA
-49.58-7.58-12.02-43.2313.31
Upgrade
EBITDA Margin
-246.41%-12.29%-20.84%-174.99%19.07%
Upgrade
D&A For EBITDA
1.995.094.414.612.23
Upgrade
EBIT
-51.58-12.67-16.43-47.831.08
Upgrade
EBIT Margin
-256.32%-20.55%-28.48%-193.60%1.55%
Upgrade
Revenue as Reported
20.1261.6457.6724.769.77
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.